Target intelligence / Profile preview

Ribosomal protein L6 pseudogene 27 (RPL6P27)

Target: RPL6P27
Molecular classification: Other (Pseudogene)

Overview

RPL6P27, or ribosomal protein L6 pseudogene 27, is a processed pseudogene on human chromosome 18. It is related by sequence to the ribosomal protein L6 gene (RPL6) but does not encode a functional protein. Like other ribosomal pseudogenes, RPL6P27 is dispersed in the human genome as a result of genomic duplication events, but lacks coding potential, regulatory activity, or clinical significance. For structured therapeutic and molecular annotation, RPL6P27 should not be considered a functional drug target. If the primary interest is in ribosomal protein L6, use RPL6 (ribosomal protein L6), which is the active component of the 60S ribosomal subunit.

Other names: RPL6_10_1582RPL6P27

Beyond the preview

Go deeper on Ribosomal protein L6 pseudogene 27 (RPL6P27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L6 pseudogene 27 (RPL6P27).

Explore the full profile